Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

Since it’s likely their patients will pursue complementary therapies during the course of their treatment ... prostate cancer progression, including biochemical recurrence, metastasis, hormone ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

Researchers at UCLA have unveiled startling findings using PSMA-PET imaging that reveal nearly half of patients diagnosed ...

Researchers found that prostate cancer patients with greater socioeconomic disadvantages were less likely to receive targeted therapy, and participation in the 340B program did not counteract that.

January 11, 2006 Long-term ... as neoadjuvant therapy for breast cancer? Mitch Dowsett, BSc, PhD, explores the latest research. July 27, 2005 Advances in Hormonal Treatment for Metastatic Breast ...

Hormone therapy has seen significant advancements, with new drugs like enzalutamide (Xtandi) and abiraterone (Zytiga) improving outcomes for men with advanced or metastatic prostate cancer.

The test identified circulating tumor DNA (ctDNA) in 59% of patients with metastatic ... cancer. "The AR-ctDETECT assay is a comprehensive panel focused on genes relevant to prostate cancer and ...